- Home
- XMAX vs CRMD Comparison
XMAX vs CRMD Comparison
Compare XMAX & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XMAX | CRMD |
|---|---|---|
| Founded | 2003 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 529.8M | 590.7M |
| IPO Year | 2009 | 2009 |
Fundamental Metrics
Financial Performance| Metric | XMAX | CRMD |
|---|---|---|
| Price | $8.44 | $8.02 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $15.33 |
| AVG Volume (30 Days) | 680.8K | ★ 985.2K |
| Earning Date | 11-13-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 88.51 | ★ 780.00 |
| EPS | 0.62 | ★ 0.72 |
| Revenue | $12,744,871.00 | ★ $311,709,000.00 |
| Revenue This Year | N/A | $8.13 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.54 | ★ $11.01 |
| Revenue Growth | N/A | ★ 617.03 |
| 52 Week Low | $8.06 | $6.13 |
| 52 Week High | $9.40 | $13.02 |
Technical Indicators
Market Signals| Indicator | XMAX | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 44.38 | 60.66 |
| Support Level | $8.33 | $7.08 |
| Resistance Level | $8.97 | $8.19 |
| Average True Range (ATR) | 0.30 | 0.28 |
| MACD | -0.00 | 0.09 |
| Stochastic Oscillator | 37.70 | 92.73 |
Price Performance
Historical ComparisonAbout XMAX XMAX Inc. Common Stock
XMax Inc is a designer and lifestyle furniture company. The company is a designer and distributor of contemporary styled residential and commercial furniture. The firms marketing and sales platform offers retail as well as online selection and purchase fulfillment internationally. The company also sells managed a variety of bedding foundation components. Its collection of lifestyle furniture brands includes Diamond Sofa. The firm's products are made in the United States and Asia. The company plans expansion into artificial intelligence (AI) while continuing to operate and develop its existing furniture business.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.